Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Patient reactions to receiving negative genomic screening results by mail.
Stuttgen K, Pacyna J, Beck A, Kullo IJ, Sharp RR. Stuttgen K, et al. Genet Med. 2020 Dec;22(12):1994-2002. doi: 10.1038/s41436-020-0906-2. Epub 2020 Jul 16. Genet Med. 2020. PMID: 32669678 Free PMC article.
Although multiple studies have examined how patients understand positive genomic screening results, few data exist regarding patient engagement with negative screening results. ...CONCLUSION: These data suggest most patie
Although multiple studies have examined how patients understand positive genomic screening results, few data exi …
Verification of wild-type EGFR status in non-small cell lung carcinomas using a mutant-enriched PCR on selected cases.
Chen YL, Lu CC, Yang SC, Su WP, Lin YL, Chen WL, Huang W, Su WC, Chow NH, Ho CL. Chen YL, et al. J Mol Diagn. 2014 Sep;16(5):486-494. doi: 10.1016/j.jmoldx.2014.05.007. Epub 2014 Jul 19. J Mol Diagn. 2014. PMID: 25051378 Free article.
EGFR genotyping is required for targeted therapy of lung adenocarcinoma. Because a false-negative result might prevent a patient from receiving appropriate targeted therapies, it is desirable to recheck equivocal results of EGFR genotyping. ...I …
EGFR genotyping is required for targeted therapy of lung adenocarcinoma. Because a false-negative result might prevent a pa